La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Mayinglong Pharmaceutical Group Bilan de santé
Santé financière contrôle des critères 5/6
Mayinglong Pharmaceutical Group has a total shareholder equity of CN¥4.0B and total debt of CN¥180.1M, which brings its debt-to-equity ratio to 4.5%. Its total assets and total liabilities are CN¥5.0B and CN¥968.7M respectively. Mayinglong Pharmaceutical Group's EBIT is CN¥452.1M making its interest coverage ratio -5.6. It has cash and short-term investments of CN¥3.0B.
Informations clés
4.5%
Ratio d'endettement
CN¥180.06m
Dette
| Ratio de couverture des intérêts | -5.6x |
| Argent liquide | CN¥3.03b |
| Fonds propres | CN¥4.04b |
| Total du passif | CN¥968.73m |
| Total des actifs | CN¥5.01b |
Mises à jour récentes de la santé financière
Recent updates
What Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) P/E Is Not Telling You
Aug 19
Mayinglong Pharmaceutical Group's (SHSE:600993) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 24Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet
Jun 19Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%
May 07Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel
Mar 22Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 600993 ( CN¥3.9B ) dépassent ses passifs à court terme ( CN¥704.9M ).
Passif à long terme: 600993's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥263.8M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 600993 has more cash than its total debt.
Réduire la dette: 600993's debt to equity ratio has increased from 1.2% to 4.5% over the past 5 years.
Couverture de la dette: 600993's debt is well covered by operating cash flow (418.9%).
Couverture des intérêts: 600993 earns more interest than it pays, so coverage of interest payments is not a concern.